Treatment of hypopharyngeal carcinoma: analysis of nationwide study in the Netherlands over a 10-year period

Clin Otolaryngol. 2005 Feb;30(1):52-7. doi: 10.1111/j.1365-2273.2004.00913.x.

Abstract

Objective: To analyse different treatment strategies and treatment results of hypopharyngeal carcinoma in the Netherlands.

Design: Retrospective study.

Setting: Eight head and neck centres in the Netherlands.

Participants: A total of 893 patients were treated between 1985 and 1994. Patients were mostly treated with radiotherapy alone, combined surgery and radiotherapy and surgery alone.

Results: The 5-year survival for the whole group was 26%. The 5-year survival for patients treated with curative intention was 32% and treated with palliative intention was 5%. The 5-year disease-free survival after radiotherapy alone was 37%, after surgery alone 41% and after combined therapy 47%. The role of chemotherapy could not be investigated because of a small number of patients treated with chemotherapy in this period.

Conclusion: Combined therapy with surgery and radiotherapy has a better survival for patients with a hypopharyngeal carcinoma in comparison with radiotherapy alone. The N-stage is more important for the prognosis than the T-stage.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell* / drug therapy
  • Carcinoma, Squamous Cell* / mortality
  • Carcinoma, Squamous Cell* / radiotherapy
  • Female
  • Humans
  • Hypopharyngeal Neoplasms* / drug therapy
  • Hypopharyngeal Neoplasms* / mortality
  • Hypopharyngeal Neoplasms* / radiotherapy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Netherlands / epidemiology
  • Retrospective Studies
  • Survival Rate